Criteria to Assess Independence in Continuing Medical Education (CME): Independence through Competence and Transparency

References

• (Model) Professional Code for Physicians in Germany, German Medical Association, 2018 Accessed 11 June, 2020: https://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/pdf-Ordner/MBO/MBO-AE_EN_2018.pdf
   Google Scholar
• (Model) Regulations on Continuing Medical Education, German Medical Association, 2013 Accessed on 11 June, 2020: https://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/pdf-Ordner/International/MFBO_2013_EN_final.pdf
   Google Scholar
• Schumm-Draeger P-M, Kapitza T, Mann K et al. Rückhalt für ärztliches Handeln (Clinic Code). Dtsch. Ärzteblatt. 2017;114:A2338-40.
   Google Scholar
• Richter-Kuhlmann E. Mut haben, etwas nicht zu tun (Be courageous not to do something). Dtsch Ärzteblatt. 2015;112:810–10.
   Google Scholar
• www.mezis.de
   Google Scholar
• www.libermed.de
   Google Scholar
• Resolution No. 3, 134th Marburger Bund General Assembly, Berlin, 2018*
   Google Scholar
• Grant J Doctors’ changing knowledge, their community of practice and CPD. Cologne Consensus Conference 2013. Accessed 11 June, 2020: https://vimeo.com/95414848
   Google Scholar
• Griebenow R, Campbell C, McMahon G, et al. Roles and responsibilities in the provision of accredited continuing medical education/continuing professional development. J Euro CME. 2017:6. DOI:10.1080/21614083.2017.1314416.
   Google Scholar
• Resolution No. 26, 127th Marburger Bund General Assembly, Frankfurt 2015*
   Google Scholar
• Resolution No. 17, 135th Marburger Bund General Assembly, Münster, 2019*
   Google Scholar
• Resolution No. 19, 129th Marburger Bund General Assembly, Hamburg, 2016*
   Google Scholar
• Flacco ME, Manzoli L, Boccia S, et al. Head-to-head randomised trials are mostly industry sponsored and almost always favour the industry sponsor. J Clin Epidemiology. 2015;68:811–820.
   PubMed Web of Science ®Google Scholar
• Rasmussen K, Bero L, Redberg R, et al. Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors. BMJ. 2018;363:k3654.
   PubMedGoogle Scholar
• Köhler M, Haag S, Biester K, et al. Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports. BMJ. 2015;350:h796.
   Web of Science ®Google Scholar
• Ross JS, Mulvey GK, Hines EM, et al. Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med. 2009;6:e1000144.
   PubMed Web of Science ®Google Scholar
• Goldacre B, DeVito NJ, Heneghan C, et al. Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource. BMJ. 2018;362:k3218.
   Google Scholar
• Resolution Ib-66, 120th German Medical Association General Assembly, Freiburg, 2017, Decision Minutes, p. 232 Accessed on 11 June, 2020: https://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/pdf-Ordner/120.DAET/Beschlussprotokoll_120_DAET.pdf
   Google Scholar
• Resolution Ib-55, 120th German Medical Association General Assembly, Freiburg, 2017, Decision Minutes, p. 154 Accessed on 11 June, 2020: https://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/pdf-Ordner/120.DAET/Beschlussprotokoll_120_DAET.pdf
   Google Scholar
• Resolution No. 16, 129th Marburger Bund General Assembly, Hamburg, 2016*
   Google Scholar
• Lösche P, Potential for change, Cologne Consensus Conference 2016 Accessed 11 June, 2020: https://vimeo.com/229917183
   Google Scholar
• Resolution No. 28, 129th Marburger Bund General Assembly, Hamburg, 2016*
   Google Scholar
• Resolution Ib-54, 120th German Medical Association General Assembly, Freiburg, 2017, Decision Minutes, p. 133 Accessed on 11 June, 2020: https://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/pdf-Ordner/120.DAET/Beschlussprotokoll_120_DAET.pdf
   Google Scholar
• Wehkamp KH, Nägler H. Economisation of patient-related decisions in hospitals. Dtsch Ärzteblatt. 2017;114:797–804.
   Google Scholar
• Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. In: Graham R, Mancher M, Miller Wolman D, et al., editors. Clinical Practice Guidelines We Can Trust. (US), Washington (DC): National Academies Press; 2011.
   Google Scholar
• Stöllberger C, Schneider B. Concerns about the ESC heart failure guidelines. Int J Cardiol. 2017;228:707–708.
   Web of Science ®Google Scholar
• Fanaroff AC, Califf RM, Windecker S, et al. Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018. JAMA. 2019;321(11):1069–1080.
   Web of Science ®Google Scholar
• Tricoci P, Allen JM, Kramer JM, et al. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA. 2009;301:831–841.
   PubMed Web of Science ®Google Scholar
• Bleß HH, de Millas C, Kern B, et al. Auswirkungen von Stellungnahmen der Wissenschaft in der Nutzenbewertung von Arzneimitteln (Effects of scientific statements in the benefit assessment of pharmaceuticals). IGES Institut GmbH, 2016
   Google Scholar
• Resolution No. 15, 129th Marburger Bund General Assembly, Hamburg, 2016*
   Google Scholar
• Resolution No. 26, 123th Marburger Bund General Assembly, Hanover, 2013*
   Google Scholar
• Resolution No. 14, 125th Marburger Bund General Assembly, Düsseldorf, 2014*
   Google Scholar
• Editors of the Heart Group Journals. Statement on matching language to the type of evidence used in describing observational studies vs. randomised trials. Eur Heart J. 2013;34:20–21.
   Web of Science ®Google Scholar
• Balshem H, Helfand M, Schunemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64:401–406.
   PubMed Web of Science ®Google Scholar
• Darrow JJ, Avorn J, Kesselheim AS. The FDA Breakthrough-Drug Designation. N Engl J Med. 2018;378:1444–1453.
   Web of Science ®Google Scholar
• Nast A, Sporbeck B, Jacobs A, et al. Perception of the binding nature of guideline recommendations. Dtsch Arztebl Int. 2013;110:663–668.
   Web of Science ®Google Scholar
• Weberschock T, Dreher A, Follmann M, et al. Bindingness of recommendations in guidelines: survey on Perception among Guideline Developers. ZEFQ. 2016;113:1–8.
   Google Scholar
• Eidemüller D. Das Weltbild der evolutionären Erkenntnistheorie (The worldview of evolutionary epistemology). In: Eidemüller D, editor. Quanten - Evolution - Geist: eine Abhandlung über Natur, Wissenschaft und Wirklichkeit (A treatise on nature, science and reality). Springer, Berlin-Heidelberg; 2017. p. 209–220. DOI:10.1007/978-3-662-49379-3_10.
   Google Scholar
• EUCJ ruling on BVV vs Teekanne, accessed 11 February, 2019: http://curia.europa.eu/juris/document/document.jsf?docid=164721&text=&doclang=EN&pageIndex=0&cid=4457975
   Google Scholar
• Recommendations on Continuing Medical Education, German Medical Association, 2015, accessed 11 June, 2020: https://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/pdf-Ordner/Fortbildung/BAEK_Recommendations_on_CME.pdf
   Google Scholar
• Resolution No. 12, 126th Marburger Bund General Assembly, Berlin, 2014
   Google Scholar